Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 55

Sort by

Sort Order Select

Journal Articles

Real-World Characterization of Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) Patients in British Columbia (BC)

Rania S. Khelifi, Steven J.T. Huang, BMLSc, Kerry J. Savage, MDMSc, Diego Villa, MDMPH, David W. Scott, MBChB, PhD, Khaled Ramadan, MBBCH, MRCP, FRCPath, Joseph M. Connors, MD, Laurie H. Sehn, MDMPH, Cynthia L Toze, MD FRCPC, Alina S. Gerrie, MD MPH

Blood (2020) 136 (Supplement 1): 33–34.

https://doi.org/10.1182/blood-2020-138887

Published: 2020

Journal Articles

Bendamustine and Rituximab As Induction Therapy in Both Transplant Eligible and Ineligible Patients with Mantle Cell Lymphoma

Diego Villa, MD MPH, Laurie H Sehn, MD, Kerry J Savage, BSc, MD MSc, Cynthia L Toze, MD FRCPC, Kevin Song, MD, Wendie L den Brok, Ciara L Freeman, MSc, MBBChir, David W. Scott, MBChB, PhD, Alina S Gerrie, MD MPH

Blood (2019) 134 (Supplement_1): 2814.

https://doi.org/10.1182/blood-2019-124217

Published: 2019

Journal Articles

Oral Fludarabine and Intravenous Rituximab (FR) for Chronic Lymphocytic Leukemia (CLL): Long Term Outcomes and Secondary Malignancies in 673 Patients Treated in British Columbia (BC)

Elysha Vanderveer, MD BSc, Steven J.T. Huang, BMLSc, Helene Bruyere, MD FCCMG, Tanya Gillan, PhD FCCMG, Charles H. Li, MDFRCPC, Khaled Ramadan, MBBCH, MRCP, FRCPath, Diego Villa, MD MPH, David W. Scott, MBChB, PhD, Kerry J Savage, BSc, MD MSc, Joseph M Connors, MD, Laurie H Sehn, MD, Cynthia L Toze, MD FRCPC, Alina S Gerrie, MD MPH

Blood (2019) 134 (Supplement_1): 4300.

https://doi.org/10.1182/blood-2019-125189

Published: 2019

Journal Articles

Less Chronic Graft-Versus-Host Disease, Immunosuppressive Therapy and Better Survival after Anti-Thymocyte Globulin in Unrelated Donor Stem Cell Transplant Recipients: Longer Follow-up of a Multicentre Cell Therapy Transplant Canada Randomized Trial

Jean Roy, MD, Tony Panzarella, M.Sc., P.Stat, Stephen Couban, MDBSc, Félix Couture, MD FRCPC, Gerald M. Devins, PhD, Mohamed Elemary, MD, Stephen Ronan Foley, MD FRCPC, Genevieve Gallagher, MD, John Kuruvilla, MD, Stephanie J. Lee, MD MPH, John Moore, MDFRACP,FRCPA, Thomas J Nevill, MD, Gizelle Popradi, MD FRCP, Kirk R. Schultz, MD, David Szwajcer, MD FRCPC, Cynthia L Toze, MD FRCPC, Irwin Walker, MBBS, FRCPC

Blood (2019) 134 (Supplement_1): 875.

https://doi.org/10.1182/blood-2019-123275

Published: 2019

Journal Articles

Unsuccessful Cytogenetics and Outcomes in Acute Leukemia

Lauren Lee, MD, Helene Bruyere, MD, Michael J Barnett, BM, Raewyn Broady, MBChB, Donna L. Forrest, MD, Alina S. Gerrie, MD MPH, Donna E. Hogge, MD PhD, Stephen H. Nantel, MD, Sujaatha Narayanan, MBBS, Maryse Power, MD, David Sanford, MD, Kevin Song, MD, Heather J. Sutherland, MD PhD, Cynthia L Toze, MD, Jennifer White, MD, Yasser Abou Mourad, MD

Blood (2018) 132 (Supplement 1): 2673.

https://doi.org/10.1182/blood-2018-99-110470

Published: 2018

Journal Articles

Characteristics of Patients (pts) Who Relapse and Die of Multiple Myeloma (MM) within One Year Post Frontline Autologous Stem Cell Transplant (ASCT) in the Novel Agent Era: An Ultra-High Risk Population

Hatem Alahwal, MPH, MBBS, Heather J. Sutherland, MD PhD, Shruthi Ganeshappa Kodad, MD, Stephen H. Nantel, MD, Yasser Abou Mourad, MD, Michael J. Barnett, BMBS, Donna L. Forrest, MD, Alina S. Gerrie, MD MPH, Donna E. Hogge, MD PhD, Sujaatha Narayanan, MBBS, MRCP, MRCPath, Thomas J. Nevill, MD, Maryse Power, MD, David Sanford, MD, Cynthia L. Toze, MD FRCPC, MSc, Jennifer White, MD, Raewyn Broady, MBChB, Kevin Song, MD

Blood (2018) 132 (Supplement 1): 3440.

https://doi.org/10.1182/blood-2018-99-111533

Published: 2018

Journal Articles

Older Adults with Acute Myeloid Leukemia in Rural Areas Are Less Likely to Receive Azacitidine with Worsened Overall Survival

Ryan J Stubbins, MD MSc, Lauren Lee, MD, Yasser Abou Mourad, MD, Michael J Barnett, BM, Raewyn Broady, MBChB, Donna L. Forrest, MD, Alina S. Gerrie, MD MPH, Donna E. Hogge, MD PhD, Stephen H. Nantel, MD, Sujaatha Narayanan, MBBS, Thomas J Nevill, MD, Maryse Power, MD, Kevin Song, MD, Heather J. Sutherland, MD PhD, Cynthia L Toze, MD, Jennifer White, MD, David Sanford, MD

Blood (2018) 132 (Supplement 1): 3989.

https://doi.org/10.1182/blood-2018-99-111532

Published: 2018

Journal Articles

Bendamustine Adversely Affects Stem Cell Mobilization Among Patients with Mantle Cell Lymphoma (MCL): A Comparison of the BR Vs RCHOP Eras in British Columbia (BC), Canada

Hatem Alahwal, MPH, MBBS, Parv Chapani, Diego Villa, MD FRCPC, Yasser Abou Mourad, MD, Maryse Power, MD, Stephen H. Nantel, MD, David Sanford, MD, Gayatri Sreenivasan, BSc, MD, Heather J. Sutherland, MD PhD, Laurie H Sehn, MD MPH, Cynthia L. Toze, MD FRCPC, MSc, Raewyn Broady, MBChB, Kevin Song, MD, Paul Yenson, MD BSc, FRCPC, Alina S. Gerrie, MD MPH

Blood (2018) 132 (Supplement 1): 4556.

https://doi.org/10.1182/blood-2018-99-114371

Published: 2018

Journal Articles

Outcomes of Intermediate Risk Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared to Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-Score Adjusted Analysis

Wasithep Limvorapitak, MD, Michael J Barnett, BM, Donna Hogge, Donna L Forrest, MD, Thomas J Nevill, MD, Sujaatha Narayanan, MBBS, Maryse Power, MB, Stephen H Nantel, MD, Raewyn Broady, MBChB, FRACP, Kevin W Song, MD, Cynthia L Toze, MD, Yasser Abou Mourad, MD, Heather Sutherland, MD, Alina S Gerrie, MD, Jennifer White, MD, David Sanford, MD

Blood (2017) 130 (Supplement 1): 4544.

https://doi.org/10.1182/blood.V130.Suppl_1.4544.4544

Published: 2017

Journal Articles

Population-Based Survival Outcomes in Adult Patients with Burkitt Lymphoma (BL) Treated with Cyclophosphamide, Vincristine, Doxorubicin, High-Dose Methotrexate (CODOX-M)/Ifosfamide, Etoposide and High-Dose Cytarabine (IVAC) Plus or Minus Rituximab (R) in British Columbia (BC), Canada

Katie Y. Zhu, BHSc, Kevin W. Song, MD, Joseph M Connors, MD, Tracy Tucker, PhD FCCMG, Graham W. Slack, MD, Yasser Abou Mourad, MD, Michael J Barnett, BMBS, FRCPC, FRCP, FRCPath, Donna L. Forrest, MD FRCPC, Donna E. Hogge, MD PhD, Stephen H. Nantel, MD FRCPC, Sujaatha Narayanan, MBBS, MRCP, FRCPath, Thomas J. Nevill, MD FRCPC, Maryse M Power, MB, MRCPI, FRCPath, David Sanford, MD FRCPC, Cynthia L. Toze, MD MHSc, FRCPC, Heather J. Sutherland, MD PhD FRCPC, Laurie H. Sehn, Raewyn Broady, MBChB, FRACP, Alina S. Gerrie, MD MPH, FRCPC

Blood (2016) 128 (22): 1113.

https://doi.org/10.1182/blood.V128.22.1113.1113

Published: 2016

Journal Articles

Outcome of Patients with Peripheral T-Cell Lymphoma Undergoing Allogeneic Stem Cell in British Columbia

Blood (2016) 128 (22): 5852.

https://doi.org/10.1182/blood.V128.22.5852.5852

Published: 2016

Journal Articles

Improving Revised International Prognostic Scoring System (IPSS-R) Pre-Allogeneic Stem Cell Transplant Does Not Translate into Better Post-Transplant Outcomes for Patients with Myelodysplastic Syndromes

Musa Alzahrani, MBBS, ABIM, Maryse M Power, MD, Emilie Nevill, Yasser Abou Mourad, MD, Michael J Barnett, BMBS, Raewyn Broady, MBChB, Donna L. Forrest, MD, Alina S. Gerrie, MD MPH, FRCPC, Donna E. Hogge, MD PhD, Stephen H. Nantel, MD FRCPC, David Sanford, MD FRCPC, Heather J. Sutherland, MD PhD FRCPC, Cynthia L. Toze, MD MHSc, FRCPC, Kevin W. Song, MD, Kevin W. Song, MD, Thomas J. Nevill, MD FRCPC, Sujaatha Narayanan

Blood (2016) 128 (22): 4662.

https://doi.org/10.1182/blood.V128.22.4662.4662

Published: 2016

Journal Articles

Long-Term Outcomes of Patients with Acute Myeloid Leukemia Treated with Salvage High-Dose Etoposide and Cyclophosphamide

Amir Siddiqui, Donna E. Hogge, MD PhD, Thomas J. Nevill, MD, Stephen H. Nantel, MD FRCPC, Michael J Barnett, BMBS, Raewyn Broady, MBChB, Donna L. Forrest, MD, Sujaatha Narayanan, MBBS, MRCP, FRCPath, Maryse M Power, MD, Kevin W. Song, MD, Cynthia L. Toze, MD MHSc, FRCPC, Yasser Abou Mourad, MD, Heather J. Sutherland, MD PhD, Alina S. Gerrie, MD MPH, FRCPC, David Sanford, MD FRCPC

Blood (2016) 128 (22): 2814.

https://doi.org/10.1182/blood.V128.22.2814.2814

Published: 2016

Journal Articles

Pediatric-Based Versus Adult Treatment Protocols in Young Adults (18-40 years) with Standard Risk Acute Lymphoblastic Leukemia: The BC Cancer Agency Experience

David Simon Kliman, MBBS, Michael J Barnett, BMBS, FRCPC, FRCP, FRCPath, Raewyn Broady, MBChB, FRACP, Donna L. Forrest, MD FRCPC, Alina S. Gerrie, MD MPH, FRCPC, Donna E. Hogge, MD PhD FRCPC, Stephen H. Nantel, MD FRCPC, Sujaatha Narayanan, MBBS, MRCP, FRCPath, Thomas J. Nevill, MD FRCPC, Maryse M Power, MB, MRCPI, FRCPath, Kevin Song, MD FRCPC, Heather J. Sutherland, MD PhD FRCPC, Cynthia L. Toze, MD MHSc, FRCPC, Yasser Abou Mourad, MD FRCPC

Blood (2015) 126 (23): 3770.

https://doi.org/10.1182/blood.V126.23.3770.3770

Published: 2015

Journal Articles

Clinical Outcomes for Chronic Lymphocytic Leukemia (CLL) Patients with 11q Deletion in British Columbia (BC), Canada: Results of a Population-Based Cohort

Jennifer Goy, MD MSc, Tanya L. Gillan, PhD FCCMG, Huang J.T. Steven, Helene Bruyere, MD FCCMG, Monica Anne Hrynchak, MD FRCPC, Aly Karsan, MD, Khaled Ramadan, MB, MRCP, MRCPath, Adam C. Smith, PhD FCCMG, FACMG, Cynthia L. Toze, MD FRCP(C), Alina S. Gerrie, MD MPH

Blood (2014) 124 (21): 2648.

https://doi.org/10.1182/blood.V124.21.2648.2648

Published: 2014

Journal Articles

Comparison of Outcomes in Chronic Lymphocytic Leukemia (CLL) with the Addition of Rituximab to Initial Treatment: A Comparative Effectiveness Analysis in the Province of British Columbia (BC), Canada

Lauren J. Lee, MD, Alina S. Gerrie, MD FRCPC, Helene Bruyere, MD FCCMG, Tanya L. Gillan, PhD FCCMG, Stephen J.T. Huang, BMLSc, Cynthia L. Toze, MD FRCPC, Khaled M. Ramadan, MBBCh, MRCPI, FRCPath, FRCP, FRCPC

Blood (2014) 124 (21): 3344.

https://doi.org/10.1182/blood.V124.21.3344.3344

Published: 2014

Journal Articles

Prognostic Factors and Outcomes in Allogeneic Hematopoietic Stem Cell Transplant Vs. Non-Transplant Chronic Lymphocytic Leukemia (CLL) Patients: A Comparative Analysis with the Leukemia/BMT Program of British Columbia (BC) and the BC Provincial CLL Database

Sebastian J. Swic, Alexander G. T. MacPhail, Chinmay B. Dalal, MD, Steven J.T. Huang, BMLSc, Alina S. Gerrie, MD FRCPC, Thomas J. Nevill, MD, Heather J. Sutherland, MD PhD FRCPC, Raewyn Broady, MBChB, Stephen H. Nantel, MD FRCPC, Sujaatha Narayanan, MBBS, MRCP, FRCPath, Kevin Song, MD, Yasser R Abou Mourad, MD FRCPC, Donna E. Hogge, MD PhD FRCPC, Maryse M. Power, MD MRCPI, FRCPath, Michael J. Barnett, BMBS, FRCPC, FRCP, FRCPath, Donna L. Forrest, MD, Sean S Young, PhD DABMG, FACMG, FCCMG, Tanya L. Gillan, PhD FCCMG, Cynthia L. Toze, MD FRCPC

Blood (2014) 124 (21): 2549.

https://doi.org/10.1182/blood.V124.21.2549.2549

Published: 2014

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Failing Treatment with Tyrosine Kinase Inhibitors

Anish Nair, MD, Michael J Barnett, BM, Donna E. Hogge, MD PhD, Kevin Song, MD, Cynthia L. Toze, MD FRCPC, Stephen H. Nantel, MD FRCPC, Maryse M Power, Sujaatha Narayanan, MBBS, MRCP, FRCPath, Raewyn Broady, MBChB, FRACP, Heather J. Sutherland, MD PhD FRCPC, Thomas J. Nevill, MD FRCPC, Yasser R Abou Mourad, MD FRCPC, Alina S. Gerrie, MD FRCPC, Donna L. Forrest, MD

Blood (2014) 124 (21): 1250.

https://doi.org/10.1182/blood.V124.21.1250.1250

Published: 2014

Journal Articles

Autoimmune Cytopenia in Chronic Lymphocytic Leukemia: Effect on Outcome and Survival, a Population Based Analysis in British Columbia, Canada

Alaa A Alzaki, MBBS, Alina S Gerrie, MD, Tanya L. Gillan, PhD FCCMG, Steven Huang, Miriam Ahmed, Cynthia L. Toze, MD FRCPC, Heather A Leitch, MD PhD, Khaled M Ramadan, MB

Blood (2014) 124 (21): 1945.

https://doi.org/10.1182/blood.V124.21.1945.1945

Published: 2014

Journal Articles

Thymoglobulin Decreases the Need for Immunosuppression at 12 Months after Myeloablative and Nonmyeloablative Unrelated Donor Transplantation: CBMTG 0801, a Randomized, Controlled Trial

Irwin Walker, MBBS, Kirk R. Schultz, MD, Cynthia L. Toze, MD FRCPC, Holly Margaret Kerr, RN, BSN, John Moore, MD, David Szwajcer, MD FRCPC, Stephen Ronan Foley, MD FRCPC, John Kuruvilla, MD FRCPC, Tony Panzarella, M.Sc, Félix Couture, MD, Jean Roy, MD, Stephen Couban, MD FRCPC, Gerald Devins, PhD, Gizelle Popradi, FRCPC, MD, Stephanie J. Lee, MD MPH, Jason Tay, MD MSc, FRCPC, Thomas J. Nevill, MD FRCPC, Mohamed Elemary, MD MSc,PhD, Genevieve Gallagher, MD FRCPC

Blood (2014) 124 (21): 38.

https://doi.org/10.1182/blood.V124.21.38.38

Published: 2014

NARROW

Real-World Characterization of Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) Patients in British Columbia (BC)

Bendamustine and Rituximab As Induction Therapy in Both Transplant Eligible and Ineligible Patients with Mantle Cell Lymphoma

Oral Fludarabine and Intravenous Rituximab (FR) for Chronic Lymphocytic Leukemia (CLL): Long Term Outcomes and Secondary Malignancies in 673 Patients Treated in British Columbia (BC)

Less Chronic Graft-Versus-Host Disease, Immunosuppressive Therapy and Better Survival after Anti-Thymocyte Globulin in Unrelated Donor Stem Cell Transplant Recipients: Longer Follow-up of a Multicentre Cell Therapy Transplant Canada Randomized Trial

Unsuccessful Cytogenetics and Outcomes in Acute Leukemia

Characteristics of Patients (pts) Who Relapse and Die of Multiple Myeloma (MM) within One Year Post Frontline Autologous Stem Cell Transplant (ASCT) in the Novel Agent Era: An Ultra-High Risk Population

Older Adults with Acute Myeloid Leukemia in Rural Areas Are Less Likely to Receive Azacitidine with Worsened Overall Survival

Bendamustine Adversely Affects Stem Cell Mobilization Among Patients with Mantle Cell Lymphoma (MCL): A Comparison of the BR Vs RCHOP Eras in British Columbia (BC), Canada

Outcomes of Intermediate Risk Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared to Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-Score Adjusted Analysis

Population-Based Survival Outcomes in Adult Patients with Burkitt Lymphoma (BL) Treated with Cyclophosphamide, Vincristine, Doxorubicin, High-Dose Methotrexate (CODOX-M)/Ifosfamide, Etoposide and High-Dose Cytarabine (IVAC) Plus or Minus Rituximab (R) in British Columbia (BC), Canada

Outcome of Patients with Peripheral T-Cell Lymphoma Undergoing Allogeneic Stem Cell in British Columbia

Improving Revised International Prognostic Scoring System (IPSS-R) Pre-Allogeneic Stem Cell Transplant Does Not Translate into Better Post-Transplant Outcomes for Patients with Myelodysplastic Syndromes

Long-Term Outcomes of Patients with Acute Myeloid Leukemia Treated with Salvage High-Dose Etoposide and Cyclophosphamide

Pediatric-Based Versus Adult Treatment Protocols in Young Adults (18-40 years) with Standard Risk Acute Lymphoblastic Leukemia: The BC Cancer Agency Experience

Clinical Outcomes for Chronic Lymphocytic Leukemia (CLL) Patients with 11q Deletion in British Columbia (BC), Canada: Results of a Population-Based Cohort

Comparison of Outcomes in Chronic Lymphocytic Leukemia (CLL) with the Addition of Rituximab to Initial Treatment: A Comparative Effectiveness Analysis in the Province of British Columbia (BC), Canada

Prognostic Factors and Outcomes in Allogeneic Hematopoietic Stem Cell Transplant Vs. Non-Transplant Chronic Lymphocytic Leukemia (CLL) Patients: A Comparative Analysis with the Leukemia/BMT Program of British Columbia (BC) and the BC Provincial CLL Database

Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Failing Treatment with Tyrosine Kinase Inhibitors

Autoimmune Cytopenia in Chronic Lymphocytic Leukemia: Effect on Outcome and Survival, a Population Based Analysis in British Columbia, Canada

Thymoglobulin Decreases the Need for Immunosuppression at 12 Months after Myeloablative and Nonmyeloablative Unrelated Donor Transplantation: CBMTG 0801, a Randomized, Controlled Trial

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only